Home › Funds › DME Capital Management, LP › TEVA

DME Capital Management, LP position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

DME Capital Management, LP reported holding 1,817,146 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$72.0M, representing 2.03% of its reported portfolio and ranking #19 among its reported holdings. DME Capital Management, LP has disclosed TEVA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)1.82M sh
Reported value held$71.96M
Portfolio Weight2.03%
First reportedQ1 2024
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DME Capital Management, LP's TEVA position evolved

DME Capital Management, LP first disclosed a stake in TEVA in Q1 2024 at 324,850 shares (US$4.6M). The position peaked in Q2 2026 at 2,886,059 shares, worth US$97.8M. Across 11 filings, DME Capital Management, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,817,146 shares valued at US$72.0M — a reduction of -1,068,913 shares quarter over quarter.. Notable position changes include a 44% increase in Q4 2024 (shares fell 30% over the following quarter), a 565% increase in Q2 2025 (shares rose 21% over the following quarter), a 37% trim in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 324.85K $4.58M New
Q2 2024 324.85K $5.28M Hold
Q3 2024 324.85K $5.85M Hold
Q4 2024 468.55K $10.33M Add
Q1 2025 568.20K $8.73M Add
Q2 2025 3.78M $63.33M Add
Q3 2025 3.78M $76.33M Hold
Q4 2025 3.06M $95.46M Reduce
Q1 2026 2.91M $87.67M Reduce
Q2 2026 2.89M $97.78M Reduce
Q3 2026 1.82M $71.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 48 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has DME Capital Management, LP held TEVA?

DME Capital Management, LP has disclosed TEVA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is DME Capital Management, LP's current position in TEVA?

As of Q3 2026, DME Capital Management, LP holds 1.82M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $71.96M, representing 2.03% of its reported portfolio and ranking #19.

Has DME Capital Management, LP been buying or selling TEVA?

In the latest 13F filing (Q3 2026), DME Capital Management, LP reduced its position in TEVA. The position peaked in Q2 2026 at 2.89M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.